Transplant-associated thrombotic microangiopathy: an unresolved complication of unrelated allogeneic transplant for hematologic diseases.

scientific article published on 19 September 2016

Transplant-associated thrombotic microangiopathy: an unresolved complication of unrelated allogeneic transplant for hematologic diseases. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/HON.2346
P8608Fatcat IDrelease_3zcb4mlr2revjmvn56pd2pjdtm
P698PubMed publication ID27641429

P50authorAchilles AnagnostopoulosQ42933010
Ioanna SakellariQ60227348
P2093author name stringEvangelia Yannaki
Eleni Gavriilaki
Ioannis Batsis
Despoina Mallouri
Gerasimos Bamihas
Kaloyannidis Kaloyannidis
V Constantinou
Zoi Boussiou
P2860cites workSirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantationQ33366979
Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantationQ33367451
Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesisQ33382787
Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioningQ33386036
Renal thrombotic microangiopathy associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.Q33396969
Thrombotic microangiopathy associated with sirolimus level after allogeneic hematopoietic cell transplantation with tacrolimus/sirolimus-based graft-versus-host disease prophylaxisQ33403897
Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adultsQ33415603
A phase-II sequential case-series study of all patients presenting to four plasma exchange centres with presumed relapsed/refractory thrombotic thrombocytopenic purpura treated with rituximabQ33421822
Modified Ham test for atypical hemolytic uremic syndromeQ33421884
The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathyQ33427838
Terminal Complement Blockade after Hematopoietic Stem Cell Transplantation Is Safe without Meningococcal Vaccination.Q40722182
Risk and prognostic factors of transplantation-associated thrombotic microangiopathy in allogeneic haematopoietic stem cell transplantation: a nested case control study.Q53091032
Successful treatment of thrombotic microangiopathy after haematopoietic stem cell transplantation with rituximabQ80155799
Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantationQ80252186
low body mass index is an independent risk factor for transplant-associated microangiopathy following total-body irradiation-based conditioning regimensQ81817471
Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantationQ83931969
P433issue4
P304page(s)932-934
P577publication date2016-09-19
P1433published inHematological OncologyQ15762617
P1476titleTransplant-associated thrombotic microangiopathy: an unresolved complication of unrelated allogeneic transplant for hematologic diseases.
P478volume35

Reverse relations

cites work (P2860)
Q92600857Allogeneic reactivity-mediated endothelial cell complications after HSCT: a plea for consensual definitions
Q64094847Complement in Thrombotic Microangiopathies: Unraveling Ariadne's Thread Into the Labyrinth of Complement Therapeutics
Q89987658Incidence, Risk Factors for and Outcomes of Transplant-Associated Thrombotic Microangiopathy
Q90499610Intestinal thrombotic microangiopathy: a distinct entity in the spectrum of graft-versus-host disease
Q92798609Transplant-Associated Thrombotic Microangiopathy Is a Multifactorial Disease Unresponsive to Immunosuppressant Withdrawal
Q30235311Transplant-associated thrombotic microangiopathy: opening Pandora's box.

Search more.